{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:22:59Z","timestamp":1779877379528,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11095-022-03395-8","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T18:02:38Z","timestamp":1664388158000},"page":"2761-2780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Design, Fabrication and Evaluation of Stabilized Polymeric mixed micelles for Effective Management in Cancer Therapy"],"prefix":"10.1007","volume":"39","author":[{"given":"Padakanti Sandeep","family":"Chary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Rajana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetanjali","family":"Devabattula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valamla","family":"Bhavana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshiyar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi Bala","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8065","authenticated-orcid":false,"given":"Neelesh Kumar","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"issue":"12","key":"3395_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2459\/JCM.0B013E328336B4C1","volume":"11","author":"N Maurea","year":"2010","unstructured":"Maurea N, et al. Women survive breast cancer but fall victim to heart failure: The shadows and lights of targeted therapy. J Cardiovasc Med. Dec. 2010;11(12):861\u20138. https:\/\/doi.org\/10.2459\/JCM.0B013E328336B4C1.","journal-title":"J Cardiovasc Med"},{"issue":"2","key":"3395_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/S10549-011-1781-Y","volume":"131","author":"ER Ahn","year":"2011","unstructured":"Ahn ER, Vogel CL. Dual HER2-targeted approaches in HER2-positive breast cancer. Breast Cancer Res Treat. 2011;131(2):371\u201383. https:\/\/doi.org\/10.1007\/S10549-011-1781-Y.","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"3395_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/BD-1999-11110","volume":"11","author":"WC Krauss","year":"1999","unstructured":"Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC. Emerging Antibody-Based HER2 (ErbB-2\/neu) Therapeutics. Breast Dis. Jan. 1999;11(1):113\u201324. https:\/\/doi.org\/10.3233\/BD-1999-11110.","journal-title":"Breast Dis"},{"key":"3395_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.JCONREL.2020.12.012","volume":"330","author":"N Malavia","year":"2021","unstructured":"Malavia N, Kuche K, Ghadi R, Jain S. A bird\u2019s eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. J Control Release. Feb. 2021;330:72\u2013100. https:\/\/doi.org\/10.1016\/J.JCONREL.2020.12.012.","journal-title":"J Control Release"},{"issue":"1","key":"3395_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-022-00386-1","volume":"8","author":"P Tarantino","year":"2022","unstructured":"Tarantino P, et al. Immunotherapy for early triple negative breast cancer: research agenda for the next decade. npj Breast Cancer. 2022;8(1):1\u20137. https:\/\/doi.org\/10.1038\/s41523-022-00386-1.","journal-title":"npj Breast Cancer"},{"issue":"5","key":"3395_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1021\/ACSABM.8B00526\/SUPPL_FILE\/MT8B00526_SI_001.PDF","volume":"1","author":"I Selestin Raja","year":"2018","unstructured":"Selestin Raja I, Thangam R, Fathima NN. Polymeric Micelle of a Gelatin-Oleylamine Conjugate: A Prominent Drug Delivery Carrier for Treating Triple Negative Breast Cancer Cells. ACS Applied Bio Mater. 2018;1(5):1725\u201334. https:\/\/doi.org\/10.1021\/ACSABM.8B00526\/SUPPL_FILE\/MT8B00526_SI_001.PDF.","journal-title":"ACS Applied Bio Mater."},{"issue":"8","key":"3395_CR7","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.21873\/ANTICANRES.12753","volume":"38","author":"NK Mehra","year":"2018","unstructured":"Mehra NK, Tekmal RR, Palakurthi S. Development and Evaluation of Talazoparib Nanoemulsion for Systemic Therapy of BRCA1-mutant Cancer. Anticancer Research. 2018;38(8):4493\u2013503. https:\/\/doi.org\/10.21873\/ANTICANRES.12753.","journal-title":"Anticancer Research"},{"issue":"2","key":"3395_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1021\/MP500720A\/ASSET\/IMAGES\/MP500720A.SOCIAL.JPEG_V03","volume":"12","author":"NK Mehra","year":"2015","unstructured":"Mehra NK, Jain NK. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery. Mol Pharm. Feb. 2015;12(2):630\u201343. https:\/\/doi.org\/10.1021\/MP500720A\/ASSET\/IMAGES\/MP500720A.SOCIAL.JPEG_V03.","journal-title":"Mol Pharm"},{"key":"3395_CR9","doi-asserted-by":"publisher","unstructured":"Su J, Zhou L, Xia MH, Xu Y, Xiang XY, Sun LK. Bcl-2 family proteins are involved in the signal crosstalk between endoplasmic reticulum stress and mitochondrial dysfunction in tumor chemotherapy resistance.\u00a0BioMed Res Inter 2014, 2014, https:\/\/doi.org\/10.1155\/2014\/234370.","DOI":"10.1155\/2014\/234370"},{"issue":"24","key":"3395_CR10","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/BLOODADVANCES.2019000937","volume":"3","author":"DA Pollyea","year":"2019","unstructured":"Pollyea DA, Amaya M, Strati P, Konopleva MY. Venetoclax for AML: changing the treatment paradigm. Blood Adv. Dec. 2019;3(24):4326\u201335. https:\/\/doi.org\/10.1182\/BLOODADVANCES.2019000937.","journal-title":"Blood Adv"},{"issue":"9","key":"3395_CR11","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1080\/10428194.2017.1283032","volume":"58","author":"P Bose","year":"2017","unstructured":"Bose P, Gandhi V, Konopleva M. Pathways and mechanisms of venetoclax resistance. Leuk Lymphoma. Sep. 2017;58(9):2026\u201339. https:\/\/doi.org\/10.1080\/10428194.2017.1283032.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"3395_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/S40265-016-0596-X","volume":"76","author":"ED Deeks","year":"2016","unstructured":"Deeks ED. Venetoclax: First Global Approval. Drugs. 2016;76(9):979\u201387. https:\/\/doi.org\/10.1007\/S40265-016-0596-X.","journal-title":"Drugs"},{"issue":"4","key":"3395_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMOA1513257\/SUPPL_FILE\/NEJMOA1513257_DISCLOSURES.PDF","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts AW, et al. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. Jan. 2016;374(4):311\u201322. https:\/\/doi.org\/10.1056\/NEJMOA1513257\/SUPPL_FILE\/NEJMOA1513257_DISCLOSURES.PDF.","journal-title":"N Engl J Med"},{"issue":"11","key":"3395_CR14","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1021\/NN202676U\/ASSET\/IMAGES\/NN202676U.SOCIAL.JPEG_V03","volume":"5","author":"H Cho","year":"2011","unstructured":"Cho H, Kwon GS. Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging. ACS Nano. Nov. 2011;5(11):8721\u20139. https:\/\/doi.org\/10.1021\/NN202676U\/ASSET\/IMAGES\/NN202676U.SOCIAL.JPEG_V03.","journal-title":"ACS Nano"},{"issue":"3","key":"3395_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/J.JCONREL.2009.04.024","volume":"140","author":"HC Shin","year":"2009","unstructured":"Shin HC, Alani AWG, Rao DA, Rockich NC, Kwon GS. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J Control Release. Dec. 2009;140(3):294\u2013300. https:\/\/doi.org\/10.1016\/J.JCONREL.2009.04.024.","journal-title":"J Control Release"},{"issue":"12","key":"3395_CR16","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/S11095-010-0233-4","volume":"27","author":"C Oerlemans","year":"2010","unstructured":"Oerlemans C, Bult W, Bos M, Storm G, Nijsen JFW, Hennink WE. Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release. Pharmaceutical Research. 2010;27(12):2569\u201389. https:\/\/doi.org\/10.1007\/S11095-010-0233-4.","journal-title":"Pharmaceutical Research"},{"key":"3395_CR17","doi-asserted-by":"publisher","unstructured":"Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials, 7(2), 145\u2013158, 2010, https:\/\/doi.org\/10.1517\/17425240903436479.","DOI":"10.1517\/17425240903436479"},{"issue":"2\u20133","key":"3395_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","volume":"73","author":"VP Torchilin","year":"2001","unstructured":"Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. Jun. 2001;73(2\u20133):137\u201372. https:\/\/doi.org\/10.1016\/S0168-3659(01)00299-1.","journal-title":"J Control Release"},{"issue":"3","key":"3395_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/J.EJPB.2008.11.010","volume":"71","author":"H Maeda","year":"2009","unstructured":"Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. Mar. 2009;71(3):409\u201319. https:\/\/doi.org\/10.1016\/J.EJPB.2008.11.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"3395_CR20","doi-asserted-by":"publisher","unstructured":"Alakhov\u00a0V, Kabanov A. Block Copolymer-Based Formulations of Doxorubicin Effective Against Drug Resistant Tumours. Biomedical Polymers and Polymer Therapeutics, 121\u2013137, 2002, https:\/\/doi.org\/10.1007\/0-306-46842-5_10.","DOI":"10.1007\/0-306-46842-5_10"},{"issue":"2\u20133","key":"3395_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"A. v. Kabanov, E. v. Batrakova, and","year":"2002","unstructured":"A. v. Kabanov, E. v. Batrakova, and V. Y. Alakhov. Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery. J Controll Release. 2002;82(2\u20133):189\u2013212. https:\/\/doi.org\/10.1016\/S0168-3659(02)00009-3.","journal-title":"J Controll Release."},{"issue":"19","key":"3395_CR22","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1021\/LA981716Z","volume":"15","author":"JE Wong","year":"1999","unstructured":"Wong JE, Duchscherer TM, Pietraru G, Cramb DT. Novel Fluorescence Spectral Deconvolution Method for Determination of Critical Micelle Concentrations Using the Fluorescence Probe PRODAN. Langmuir. Sep. 1999;15(19):6181\u20136. https:\/\/doi.org\/10.1021\/LA981716Z.","journal-title":"Langmuir"},{"issue":"11","key":"3395_CR23","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/J.BIOMATERIALS.2010.12.039","volume":"32","author":"W Zhang","year":"2011","unstructured":"Zhang W, Shi Y, Chen Y, Ye J, Sha X, Fang X. Multifunctional Pluronic P123\/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. Apr. 2011;32(11):2894\u2013906. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2010.12.039.","journal-title":"Biomaterials"},{"issue":"2\u20133","key":"3395_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/J.JCONREL.2003.10.018","volume":"94","author":"KT Oh","year":"2004","unstructured":"Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic\u00ae block copolymers. J Control Release. 2004;94(2\u20133):411\u201322. https:\/\/doi.org\/10.1016\/J.JCONREL.2003.10.018.","journal-title":"J Control Release."},{"issue":"1\u20132","key":"3395_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/J.IJPHARM.2005.08.026","volume":"306","author":"L Mu","year":"2005","unstructured":"Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)\u2013phosphatidylethanolamine conjugate and d-\u03b1-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm. Dec. 2005;306(1\u20132):142\u20139. https:\/\/doi.org\/10.1016\/J.IJPHARM.2005.08.026.","journal-title":"Int J Pharm"},{"issue":"1","key":"3395_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/J.JCONREL.2004.09.021","volume":"102","author":"ZG Gao","year":"2005","unstructured":"Gao ZG, Fain HD, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release. Jan. 2005;102(1):203\u201322. https:\/\/doi.org\/10.1016\/J.JCONREL.2004.09.021.","journal-title":"J Control Release"},{"issue":"15","key":"3395_CR27","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1016\/J.BIOMATERIALS.2014.02.022","volume":"35","author":"NK Mehra","year":"2014","unstructured":"Mehra NK, Verma AK, Mishra PR, Jain NK. The cancer targeting potential of d-\u03b1-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Biomaterials. May 2014;35(15):4573\u201388. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2014.02.022.","journal-title":"Biomaterials"},{"key":"3395_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1155\/2012\/916573","volume":"2012","author":"AM Butt","year":"2012","unstructured":"Butt AM, Amin MCIM, Katas H, Sarisuta N, Witoonsaridsilp W, Benjakul R. In vitro characterization of pluronic F127 and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate mixed micelles as nanocarriers for targeted anticancer-drug delivery. J Nanomater. Jan. 2012;2012:11. https:\/\/doi.org\/10.1155\/2012\/916573.","journal-title":"J Nanomater"},{"issue":"10","key":"3395_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/J.1745-7254.2008.00851.X","volume":"29","author":"XY Lei","year":"2008","unstructured":"Lei XY, et al. Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-71. Acta Pharmacol Sin. Oct. 2008;29(10):1233\u20139. https:\/\/doi.org\/10.1111\/J.1745-7254.2008.00851.X.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"3395_CR30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/CBDD.13578","volume":"94","author":"NS Goud","year":"2019","unstructured":"Goud NS, et al. Synthesis and biological evaluation of morpholines linked coumarin\u2013triazole hybrids as anticancer agents. Chem Biol Drug Des. Nov. 2019;94(5):1919\u201329. https:\/\/doi.org\/10.1111\/CBDD.13578.","journal-title":"Chem Biol Drug Des"},{"issue":"6","key":"3395_CR31","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1002\/JCP.29413","volume":"235","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda S, Pooladanda V, Godugu C. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation. J Cell Physiol. Jun. 2020;235(6):5270\u201383. https:\/\/doi.org\/10.1002\/JCP.29413.","journal-title":"J Cell Physiol"},{"key":"3395_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/J.JINORGBIO.2018.05.005","volume":"186","author":"J Qi","year":"2018","unstructured":"Qi J, Yao Q, Qian K, Tian L, Cheng Z, Wang Y. Gallium(III) complexes of \u03b1-N-heterocyclic piperidylthiosemicarbazones: Synthesis, structure-activity relationship, cellular uptake and activation of caspases-3\/7\/9. J Inorg Biochem. Sep. 2018;186:42\u201350. https:\/\/doi.org\/10.1016\/J.JINORGBIO.2018.05.005.","journal-title":"J Inorg Biochem"},{"issue":"1","key":"3395_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-019-6169-0\/FIGURES\/6","volume":"20","author":"YL Sun","year":"2019","unstructured":"Sun YL, et al. A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway. BMC Cancer. Dec. 2019;20(1):1\u201312. https:\/\/doi.org\/10.1186\/S12885-019-6169-0\/FIGURES\/6.","journal-title":"BMC Cancer"},{"key":"3395_CR34","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2147\/IJN.S153094","volume":"13","author":"A Patra","year":"2018","unstructured":"Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int J Nanomed. May 2018;13:2869. https:\/\/doi.org\/10.2147\/IJN.S153094.","journal-title":"Int J Nanomed"},{"issue":"3","key":"3395_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/CRYST11030261","volume":"11","author":"F Perdih","year":"2021","unstructured":"Perdih F, \u017digart N, \u010casar Z. Crystal Structure and Solid-State Conformational Analysis of Active Pharmaceutical Ingredient Venetoclax. Crystals. 2021;11(3):261. https:\/\/doi.org\/10.3390\/CRYST11030261.","journal-title":"Crystals"},{"key":"3395_CR36","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2147\/IJN.S28745","volume":"7","author":"V Saxena","year":"2012","unstructured":"Saxena V, Delwar Hussain M. Poloxamer 407\/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int J Nanomedicine. 2012;7:713. https:\/\/doi.org\/10.2147\/IJN.S28745.","journal-title":"Int J Nanomedicine."},{"key":"3395_CR37","doi-asserted-by":"publisher","unstructured":"Zakaria AS, Afifi SA, Elkhodairy KA. Newly Developed Topical Cefotaxime Sodium Hydrogels: Antibacterial Activity and in Vivo Evaluation. BioMed Res Int\u00a02016;2016, https:\/\/doi.org\/10.1155\/2016\/6525163.","DOI":"10.1155\/2016\/6525163"},{"issue":"1","key":"3395_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.IJPHARM.2010.10.037","volume":"418","author":"DR Paul","year":"2011","unstructured":"Paul DR. Elaborations on the Higuchi model for drug delivery. Int J Pharm. Oct. 2011;418(1):13\u20137. https:\/\/doi.org\/10.1016\/J.IJPHARM.2010.10.037.","journal-title":"Int J Pharm"},{"issue":"3","key":"3395_CR39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1021\/MP060121R\/ASSET\/IMAGES\/MP060121R.SOCIAL.JPEG_V03","volume":"4","author":"EM Collnot","year":"2007","unstructured":"Collnot EM, et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidity. Mol Pharm. May 2007;4(3):465\u201374. https:\/\/doi.org\/10.1021\/MP060121R\/ASSET\/IMAGES\/MP060121R.SOCIAL.JPEG_V03.","journal-title":"Mol Pharm"},{"issue":"10","key":"3395_CR40","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/S12272-011-1016-0","volume":"34","author":"Y Guan","year":"2011","unstructured":"Guan Y, et al. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism. Arch Pharm Res. 2011;34(10):1719\u201328. https:\/\/doi.org\/10.1007\/S12272-011-1016-0.","journal-title":"Arch Pharm Res."},{"issue":"3","key":"3395_CR41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3\/2\/45-3-528-FIG2.GIF","volume":"45","author":"A Saraste","year":"2000","unstructured":"Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. Feb. 2000;45(3):528\u201337. https:\/\/doi.org\/10.1016\/S0008-6363(99)00384-3\/2\/45-3-528-FIG2.GIF.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3395_CR42","doi-asserted-by":"publisher","first-page":"pdb.prot5556","DOI":"10.1101\/PDB.PROT5556","volume":"2011","author":"B Chazotte","year":"2011","unstructured":"Chazotte B. Labeling Nuclear DNA Using DAPI. Cold Spring Harbor Protocols. 2011;2011(1):pdb.prot5556. https:\/\/doi.org\/10.1101\/PDB.PROT5556.","journal-title":"Cold Spring Harbor Protocols"},{"issue":"1","key":"3395_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6750-5-12\/TABLES\/1","volume":"5","author":"D Ribble","year":"2005","unstructured":"Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. May 2005;5(1):1\u20137. https:\/\/doi.org\/10.1186\/1472-6750-5-12\/TABLES\/1.","journal-title":"BMC Biotechnol"},{"issue":"6","key":"3395_CR44","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/J.FREERADBIOMED.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biol Med. Mar. 2010;48(6):749\u201362. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2009.12.022.","journal-title":"Free Radical Biol Med"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03395-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03395-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03395-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T16:22:05Z","timestamp":1667492525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03395-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3395"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03395-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest related to manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}